-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
There is a lack of population-based evidence for the association between diabetes and biliary tract cancer (BTC) risk
diabetes
Recently, Metabolism-Clinical and Experimental, an authoritative journal in the field of metabolic diseases, published a research article that aims to assess the association between pre-diabetes, diabetes and diabetes course and the subsequent risk of BTC in the Korean general population, including cholangiocarcinoma (CCA) and Gallbladder Cancer (GBC)
This national cohort study included 9697773 adults over 20 years of age who did not suffer from cancer.
Screening diagnosis
Biliary cancer risk
During a median follow-up of 7.
It can be seen that IFG and diabetes are independently associated with increased BTC risk, including CCA and GBC
Both IFG and diabetes are independently associated with increased BTC risk, including CCA and GBC
Original source:
Joo-Hyun Park.